We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,365 hedge funds and large institutions have $173B invested in Thermo Fisher Scientific in 2023 Q3 according to their latest regulatory filings, with 141 funds opening new positions, 967 increasing their positions, 887 reducing their positions, and 135 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 967 | Existing positions reduced: 887

4% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 135

0.89% less ownership

Funds ownership: 89.44%88.54% (-0.89%)

1% less funds holding

Funds holding: 2,3882,365 (-23)

2% less call options, than puts

Call options by funds: $1.23B | Put options by funds: $1.25B

3% less capital invested

Capital invested by funds: $178B → $173B (-$4.73B)

1% less funds holding in top 10

Funds holding in top 10: 141139 (-2)

Holders
2,365
Holders Change
-23
Holders Change %
-0.96%
% of All Funds
37.53%
Holding in Top 10
139
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-1.42%
% of All Funds
2.21%
New
141
Increased
967
Reduced
887
Closed
135
Calls
$1.23B
Puts
$1.25B
Net Calls
-$26.6M
Net Calls Change
+$128M
Name Holding Trade Value Shares
Change
Change in
Stake
HSA
726
HBK Sorce Advisory
Pennsylvania
$6.83M -$232K -435 -3%
RSVP
727
Ramsay Stattman Vela & Price
Colorado
$6.83M +$3.96M +7,423 +122%
WCA
728
Waratah Capital Advisors
Ontario, Canada
$6.83M +$5.24M +9,829 +268%
CC
729
Cannell & Co
New York
$6.81M -$77.3K -145 -1%
MAM
730
Morse Asset Management
Connecticut
$6.75M +$88.5K +166 +1%
CIA
731
Choate Investment Advisors
Massachusetts
$6.74M +$1.96M +3,679 +38%
CC
732
Codex Capital
New York
$6.72M
VanEck Associates
733
VanEck Associates
New York
$6.68M -$1.04M -1,954 -13%
TCM
734
Thames Capital Management
New Jersey
$6.68M
PCIA
735
Prime Capital Investment Advisors
Kansas
$6.65M +$2.49M +4,671 +55%
BFA
736
Bragg Financial Advisors
North Carolina
$6.64M +$326K +612 +5%
MWM
737
Marietta Wealth Management
Georgia
$6.62M -$7.99K -15 -0.1%
MIP
738
Marietta Investment Partners
Wisconsin
$6.6M -$151K -284 -2%
BAMF
739
BI Asset Management Fondsmaeglerselskab
Denmark
$6.6M -$20.2M -37,978 -74%
NIMI
740
Natixis Investment Managers International
France
$6.58M -$334K -626 -5%
HFS
741
Haverford Financial Services
Pennsylvania
$6.56M -$20.2K -38 -0.3%
GI
742
Gradient Investments
Minnesota
$6.54M +$542K +1,018 +9%
IDP
743
In-Depth Partners
Florida
$6.53M +$802K +1,505 +13%
MCWS
744
McKinley Carter Wealth Services
West Virginia
$6.51M -$49K -92 -0.7%
BCM
745
BTC Capital Management
Iowa
$6.5M +$27.7K +52 +0.4%
AC
746
Arjuna Capital
North Carolina
$6.5M +$258K +485 +4%
GI
747
GS Investments
Minnesota
$6.47M +$10.7K +20 +0.2%
GT
748
Greenleaf Trust
Michigan
$6.41M -$52.2K -98 -0.8%
PIM
749
Progressive Investment Management
Oregon
$6.36M -$67.1K -126 -1%
FM
750
Freemont Management
Switzerland
$6.33M -$1.12M -2,100 -14%

TMO Hedge Fund Activity: Q3 2023 in Review

2,365 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2023, worth a combined $173B — down 2.7% from $178B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new TMO positions and 135 closed out — a net gain of 6 holders — while 967 added to existing stakes and 887 trimmed.

The largest buyer was DZ Bank, adding an estimated $755M. The largest seller was Arthur M. Cohen & Associates, cutting an estimated $1.66B.

  • 2,365 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2023, down from 2,388 in Q2 2023.
  • Funds reported $173B of Thermo Fisher Scientific stock for Q3 2023, down 2.7% quarter-over-quarter.
  • 141 funds opened new Thermo Fisher Scientific positions in Q3 2023 and 135 closed out, a net change of +6 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2023 was DZ Bank, an estimated $755M added.
  • The largest Thermo Fisher Scientific seller in Q3 2023 was Arthur M. Cohen & Associates, an estimated $1.66B sold.

Based on aggregated 13F filings for Q3 2023.